Dietary Management of Hyperphosphatemia
نویسندگان
چکیده
منابع مشابه
[Management of hyperphosphatemia in CKD].
2.2 Na DRC estágios III e IV, a ingestão dietética de P deverá ser mantida em valores que atendam a recomendação de proteínas entre 0,6 e 0,8 g/kg/dia, porém não superior a 700 mg/dia se o P estiver acima dos valores normais e/ou se o paratormônio (PTH) estiver acima do nível recomendado para o estágio da DRC (Opinião). 2.3 Na DRC estágio V D, a ingestão dietética de P deverá estar entre 800 e ...
متن کاملNew developments in hyperphosphatemia management.
Patients with chronic renal failure have many associated medical problems, including a high propensity for cardiovascular disease (CVD). CVD and stroke are the leading causes of mortality in patients with ESRD (chronic kidney disease stage 5), with a 10to 20-fold greater risk than in the general population (1,2). These data have generated greater awareness of cardiovascular risk in the chronic ...
متن کاملHyperphosphatemia
تافعاضلماو تايفولل اًيسيئر اًببس مدلا يف تافسوفلا عافترا ربتعي ةليوط ةدم ذنم تتبث دقلو .نمزلما يولكلا روصقلا ىضرم دنع ضارمأ نم ةافولا رطخ ةدايزو مدلاب تافسوفلا عافترا ينب ام ةقلاعلا حملالما ةلاقلما هذه ضرعتست .يئاعولا سلكتلاو ةيئاعولا بلقلا اهتحضوأ امك ةيئاعولا تاسلكتلل ةيضارملإا ةيلمعلل ةديدلجا يف روفسوفلل زيملما يميظنتلا رودلا ةًرهظم ةثيدلحا ثوحبلا ةيللآا هذه .ةيومدلا ةيعولأل ءاسللما ةيلضعلا ايل...
متن کاملDRUG EVALUATION Sevelamer carbonate in the management of hyperphosphatemia
10.2217/14750708.5.4.545 © 2 Sevelamer carbonate appears to be a promising new agent in the control of serum phosphorus levels in subjects with chronic kidney disease. It contains the same active moiety as sevelamer hydrochloride, but has carbonate instead of chloride as the counterion. This substitution has resulted in a statistically significant improvement in serum bicarbonate levels in chro...
متن کاملPatient education for hyperphosphatemia management: Improving outcomes while decreasing costs?
modialysis patients, behavioral changes associated with the management of hyperphosphatemia, such as the adoption of a low phosphate diet and judicious intake of phosphate binders, are probably the most complicated and challenging [1,2]. Non-adherence to low phosphate diets, which are likely the most common dietary restrictions required from this patient population, ranges between 19 and 57% [3...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Kidney Diseases
سال: 2018
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2018.03.011